285 related articles for article (PubMed ID: 16601231)
1. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
[TBL] [Abstract][Full Text] [Related]
2. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
Jaulmes A; Janvier B; Andreani M; Raymondjean M
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
[TBL] [Abstract][Full Text] [Related]
3. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
4. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
Murakami M; Kudo I
Curr Opin Lipidol; 2003 Oct; 14(5):431-6. PubMed ID: 14501581
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
6. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
Bostrom MA; Boyanovsky BB; Jordan CT; Wadsworth MP; Taatjes DJ; de Beer FC; Webb NR
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):600-6. PubMed ID: 17204667
[TBL] [Abstract][Full Text] [Related]
7. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
[TBL] [Abstract][Full Text] [Related]
8. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
Wooton-Kee CR; Boyanovsky BB; Nasser MS; de Villiers WJ; Webb NR
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
[TBL] [Abstract][Full Text] [Related]
10. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
11. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.
Tada K; Murakami M; Kambe T; Kudo I
J Immunol; 1998 Nov; 161(9):5008-15. PubMed ID: 9794438
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
13. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
Menschikowski M; Hagelgans A; Siegert G
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):1-33. PubMed ID: 16516807
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2.
Dieter P; Kolada A; Kamionka S; Schadow A; Kaszkin M
Cell Signal; 2002 Mar; 14(3):199-204. PubMed ID: 11812647
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
Ghesquiere SA; Gijbels MJ; Anthonsen M; van Gorp PJ; van der Made I; Johansen B; Hofker MH; de Winther MP
J Lipid Res; 2005 Feb; 46(2):201-10. PubMed ID: 15576846
[TBL] [Abstract][Full Text] [Related]
16. Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain.
Lin TN; Wang Q; Simonyi A; Chen JJ; Cheung WM; He YY; Xu J; Sun AY; Hsu CY; Sun GY
J Neurochem; 2004 Aug; 90(3):637-45. PubMed ID: 15255941
[TBL] [Abstract][Full Text] [Related]
17. Labour is associated with increased expression of type-IIA secretory phospholipase A2 but not type-IV cytosolic phospholipase A2 in human myometrium.
Slater DM; Astle S; Bennett PR; Thornton S
Mol Hum Reprod; 2004 Nov; 10(11):799-805. PubMed ID: 15361552
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cytokine-induced expression of secretory phospholipase A2-type IIA by protein kinase C in rat renal mesangial cells.
Scholz K; Vlachojannis GJ; Spitzer S; Schini-Kerth V; Van Den Bosch H; Kaszkin M; Pfeilschifter J
Biochem Pharmacol; 1999 Dec; 58(11):1751-8. PubMed ID: 10571249
[TBL] [Abstract][Full Text] [Related]
19. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
Schiering A; Menschikowski M; Mueller E; Jaross W
Atherosclerosis; 1999 May; 144(1):73-8. PubMed ID: 10381280
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M
J Lipid Res; 2005 Aug; 46(8):1604-14. PubMed ID: 15897607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
